METOCLOPRAMIDE
Strength10 mg
Formoral.solid
10 mg orally three times daily 30 minutes before meals (max 5 days per EMA/EDA guidance) - Shortest duration necessary (max 5 days per EMA/EDA guidance for acute flares)
Contraindicated in children under 1 year; restricted because of the extrapyramidal risk. The Egyptian National Drug Formulary - Gastrointestinal Tract, metoclopramide monograph, lists among its contra-indications any use in a neonate or in a child below 1 year, on the grounds of a raised risk of extrapyramidal disorders and of methaemoglobinaemia.
Alternatives. Metoclopramide is the only prokinetic approved for diabetic gastroparesis by both the FDA and the EDA. Limit to 5 days - tardive dyskinesia is the reason domperidone is often chosen instead.
Metoclopramide 10mg SmPC (https://www.medicines.org.uk/emc/product/2355/smpc)
Metoclopramide is the only FDA and EDA approved prokinetic agent for diabetic gastroparesis, but treatment duration is strictly limited to minimize risk of extrapyramidal movement disorders.
- BLACK BOX WARNING for tardive dyskinesia (irreversible involuntary movements), especially with prolonged treatment (>12 weeks) or in elderly patients.
- Contraindicated in gastrointestinal hemorrhage, mechanical obstruction, perforation, or pheochromocytoma.
- Discontinue immediately if extrapyramidal symptoms, acute dystonia, parkinsonism, or akathisia occur.
| Egyptian brand | Manufacturer | Indicative price |
|---|---|---|
| CLOPRAM 10MG 20 TAB. | EL NASR | 3.00 EGP (0.15/unit) |
| PLEMAZOL 10MG 20 TAB. | CID | 3.20 EGP (0.16/unit) |
| VOMAWAY 10MG 20 TAB. | MEMPHIS | 8.50 EGP (0.42/unit) |
| PRIMPERAN 10MG 10 SCORED TAB. | SANOFI | 10.50 EGP |